Glycemicon is located in Brugg, Switzerland on Badenerstrasse 13. Glycemicon is rated 3 out of 5 in the category research in Switzerland. Glycemicon AG is a Swiss biotechnology company developing novel nutraceuticals for managing prediabetes, diabetes and obesity. Glycemicon - Switzerland.
Address
Badenerstrasse 13
Accessibility
Wheelchair-accessible entrance